Cirius Therapeutics, Inc. — Form D

Cirius Therapeutics, Inc. of GRAND RAPIDS, MI, a company, filed a Form D exempt-offering notice with the SEC on 2024-10-15. The offering totals $1.6M, of which $1.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
Michael JandernoaDirectorKalamazoo, MI
David Van AndelDirectorGrand Rapids, MI
Robert ZerbeDirectorGrand Rapids, MI
Robert BeardsleyExecutive OfficerSt. Louis, MO
Jerry CallahanExecutive OfficerGrand Rapids, MI
Mark OlesnavageExecutive OfficerKalamazoo, MI
Michael A JandernoaDirectorGrand Rapids, MI
Robert A BeardsleyExecutive OfficerGrand Rapids, MI
Robert A ZerbeDirectorGrand Rapids, MI
David A Van AndelDirectorGrand Rapids, MI
Jerry A CallahanExecutive OfficerGrand Rapids, MI
Elaine SunDirectorSOUTH SAN FRANCISCO, CA
Daniel EstesDirectorCarmel, IN
Nilesh KumarDirectorWatertown, MA
Daniel Estes, Ph.D.DirectorMenlo Park, CA
Baltera BobDirectorSan Diego, CA
Baltera BobExecutive OfficerSan Diego, CA
Nilesh Kumar, Ph.D.DirectorSan Diego, CA
Robert Zerbe, M.D.DirectorSan Diego, CA
Dennis Fenton, Ph.D.DirectorSan Diego, CA
Brian FarmerExecutive OfficerSan Diego, CA
Robert BalteraDirectorKalamazoo, MI
Robert BalteraExecutive OfficerKalamazoo, MI
Howard DittrichExecutive OfficerKalamazoo, MI

Other filings by this issuer (5)

FiledFormOfferingSold
2025-10-08D$1.2M$800K
2024-08-20D$1.3M$1.3M
2019-05-14D$7.5M$7.5M
2018-08-30D$9.0M$9.0M
2017-04-10D$40.5M$30.0M

More